Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Microbial glycosidation of some anthracycline antibiotics by an antibiotic-negative mutant of aclarubicin producer.

The Journal of antibiotics - 1 Aug 1993

Johdo O, Tone H, Okamoto R, Yoshimoto A, Naganawa H, Sawa T, Takeuchi T

Abstract excerpt

Microbial conversion of anthracyclinone monosaccharides using aclarubicin-negative mutant of Streptomyces galilaeus was found to produce anthracyclinone disaccharides which had either rhodinose or 2-deoxyfucose as an additional sugar. By this conversion we obtained twelve new anthracyclines from seven anthracyclines which had rhodosamine, N-monomethyldaunosamine or daunosamine at C-7 as a glycosidic sugar. All...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotics, Antineoplastic
Share to Glycosylation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Leukemia L1210

Share to Mutation

Share to Streptomyces

Share to Structure-Activity Relationship

Share to Tumor Cells, Cultured

Source

Identifiers

PMID: 8407584
DOI: 10.7164/antibiotics.46.1219

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Microbial glycosidation of some anthracycline antibiotics by an antibiotic-negative mutant of aclarubicin producer.PMID 8407584Read ↗

New betaclamycin and aclarubicin analogs obtained by prolonged microbial conversion with an aclarubicin-negative mutant.Semantic proximity Read ↗

A gene cluster from Streptomyces galilaeus involved in glycosylation of aclarubicin.Semantic proximity Read ↗

Production of new anthracycline antibiotic betaclamycin B by microbial conversion with a specific aclacinomycin-negative mutant.Semantic proximity Read ↗

Cytotoxic Anthracycline Metabolites from a Recombinant StreptomycesSemantic proximity Read ↗

Identification of Late‐Stage Glycosylation Steps in the Biosynthetic Pathway of the Anthracycline NogalamycinSemantic proximity Read ↗

Biosynthetic AnthracyclinesSemantic proximity Read ↗

Expanding the Chemical Diversity of the Antitumoral Compound Mithramycin by Combinatorial Biosynthesis and Biocatalysis: The Quest for Mithralogs with Improved Therapeutic WindowSemantic proximity Read ↗

Metabolic engineering of Streptomyces peucetius for biosynthesis of N,N-dimethylated anthracyclinesSemantic proximity Read ↗

Characterization of mutations in aclacinomycin A-non-producing Streptomyces galilaeus strains with altered glycosylation patterns.Semantic proximity Read ↗

One-Pot Combinatorial Biosynthesis of Glycosylated Anthracyclines by Cocultivation of Streptomyces Strains Producing Aglycones and Nucleotide Deoxysugars.Semantic proximity Read ↗

Engineered biosynthesis of glycosylated derivatives of narbomycin and evaluation of their antibacterial activities.Semantic proximity Read ↗

Generation of new derivatives of the antitumor antibiotic mithramycin by altering the glycosylation pattern through combinatorial biosynthesis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.